首页> Blood> Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.

Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Elliot,Stieglitz

第一单位： Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA;

作者： Elliot,Stieglitz ^[1] ; Camille B,Troup ^[2] ; Laura C,Gelston ^[1] ; John,Haliburton ^[3] ; Eric D,Chow ^[4] ; Kristie B,Yu ^[1] ; Jon,Akutagawa ^[1] ; Amaro N,Taylor-Weiner ^[5] ; Y Lucy,Liu ^[6] ; Yong-Dong,Wang ^[7] ; Kyle,Beckman ^[1] ; Peter D,Emanuel ^[6] ; Benjamin S,Braun ^[1] ; Adam,Abate ^[3] ; Robert B,Gerbing ^[8] ; Todd A,Alonzo ^[9] ; Mignon L,Loh ^[10]

作者单位： Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA; ^[1] Bio-Rad Laboratories, Hercules, CA; ^[2] Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, CA; ^[3] Center for Advanced Technology, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA; ^[4] Broad Institute, Cambridge, MA; ^[5] Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR; ^[6] Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN; ^[7] Children's Oncology Group, Monrovia, CA; ^[8] Keck School of Medicine, University of Southern California, Los Angeles, CA; and. ^[9] Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA. ^[10]